Leaky Gut, Leaky Brain
Your provider will help determine an appropriate schedule during consultation
This includes comprehensive doctor consultations, necessary lab work, carefully sourced medications from FDA-registered and inspected pharmacies, and continuous support
To date, the SURPASS program includes nine ongoing randomized controlled trials in patients with type2 diabetes: SURPASS 1 in monotherapy, SURPASS 2 versus semaglutide, SURPASS 3 versus degludec, SURPASS 4 versus glargine and established CV disease, SURPSS 5 basal insulin add-on, SURPASS AP- Combo versus glargine, and SURPASS-CVOT
7: e016434
This dual approach, validated through extensive Mounjaro clinical trials, offers distinct advantages over single-pathway medications like semaglutide (Wegovy/Ozempic), liraglutide (Saxenda), and dulaglutide (Trulicity)